What is Lenvima
Approved as Treatment by the FDALenvatinib, also known as Lenvima, is approved by the FDA for 7 uses like Microsatellite Instability High and previous anti-angiogenic therapy .
When to interrupt dosageThe endorsed dosage of Lenvima is contingent upon the indicated condition, including Malignant Neoplasms, progressive radioactive iodine-refractory Thyroid cancer and Malignant Neoplasms. The quantity of dosage shifts as per the technique of delivery featured in the following table.
WarningsThere are 20 known major drug interactions with Lenvima.
Lenvima Novel Uses: Which Conditions Have a Clinical Trial Featuring Lenvima?Fifteen active clinical trials are being conducted to analyze the potential of Lenvima to treat Malignant Neoplasms, Advanced Renal Cell Carcinoma (aRCC) and Progressive Radioactive Iodine-Refractory Thyroid Cancer.
Lenvima Reviews: What are patients saying about Lenvima?
Patient Q&A Section about lenvima
Is Lenvima a chemo drug?
"It is used to treat cancer that affects the kidney, thyroid, and liver.
Lenvima is a chemotherapy drug that inhibits the growth of cancer cells by blocking the enzyme tyrosine kinase. It is most commonly used to treat kidney, thyroid, and liver cancers." - Anonymous Online Contributor
What are the side effects of Lenvima?
"The text is discussing the side effects of the drug LENVIMA. The most common side effects include fatigue, joint and muscle pain, decreased appetite, weight loss, nausea, mouth sores, headache, vomiting, and skin rashes. Additionally, some people may experience abdominal pain and hoarseness." - Anonymous Online Contributor
What does the drug Lenvima do?
"LENVIMA is a kinase inhibitor.
LENVIMA is a prescription medication used to treat different types of cancer, including differentiated thyroid cancer (DTC). DTC is a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing. LENVIMA is a kinase inhibitor." - Anonymous Online Contributor